FDA accepts Biologics License Application for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the US January 14, 2025
Klaria signs license agreement for Sumatriptan Alginate film in Europe with CNX Therapeutics January 10, 2025
TF Bank’s Swedish subsidiary has been granted a license to operate as a deposit taking financial institution December 6, 2024
US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab) October 30, 2024
